CHROMOGRANIN-A IMMUNOREACTIVITY IN HUMAN CEREBROSPINAL-FLUID - PROPERTIES, RELATIONSHIP TO NORADRENERGIC NEURONAL-ACTIVITY, AND VARIATION IN NEUROLOGIC DISEASE

被引:20
作者
OCONNOR, DT
CERVENKA, JH
STONE, RA
PARMER, RJ
FRANCOBOURLAND, RE
MADRAZO, I
LANGLAIS, PJ
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093
[3] DEPT VET AFFAIRS MED CTR,SAN DIEGO,CA
[4] INST NACL NUTR SALVADOR ZUBIRAN,DEPT BIOQUIM,MEXICO CITY 14000,DF,MEXICO
[5] INST MEXICANO SEGURO SOCIAL,DEPT INVEST CLIN NEUROL & NEUROCIRUGIA,CTR MED SIGLO XXI,MEXICO CITY 7,DF,MEXICO
关键词
D O I
10.1016/0306-4522(93)90146-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although measurement of chromogranin A in the bloodstream is of value in sympathoadrenal investigations, little is systematically known about chromogranin A in cerebrospinal fluid, despite substantial knowledge about its occurrence and distribution in brain. We therefore applied a homologous human chromogranin A radioimmunoassay to cerebrospinal fluid, in order to evaluate the properties and stability of cerebrospinal fluid chomogranin A, as well as its relationship to central noradrenergic neuronal activity, to peripheral (plasma) chromogranin A, and to disease states such as hypertension, renal failure and Parkinsonism. Authentic, physically stable chromogranin A immunoreactivity was found in cerebrospinal fluid (at 37-146 ng/ml; mean, 87.0 +/- 6.0 ng/ml in healthy subjects), and several lines of evidence (including 3.39 +/- 0.27-fold higher chromogranin A in cerebrospinal fluid than in plasma) indicated that it originated from a local central nervous system source, rather than the periphery. Cerebrospinal fluid chromogranin A values were not influenced by administration of effective antihypertensive doses of clonidine or propranolol, and were not related to the cerebrospinal fluid concentrations of norepinephrine, methoxyhydroxyphenylglycol, or dopamine-beta-hydroxylase; thus, cerebrospinal fluid chromogranin A was not closely linked to biochemical or pharmacologic indices of central noradrenergic neuronal activity. Cerebrospinal fluid chromogranin A was not changed (P > 0. 1) in essential hypertension (84.2 +/- 14.0 ng/ml) or renal failure (72.2 +/- 13.4 ng/ml), despite a marked (7.1-fold; P < 0.001) increase in plasma chromogranin A in renal failure, and a modest (1.5-fold; P = 0.004) increase in plasma chromogranin A in essential hypertension. In Parkinson's disease, a diminution (2.8-fold; P < 0.001) of cerebrospinal fluid chromogranin A may be of diagnostic value.
引用
收藏
页码:999 / 1007
页数:9
相关论文
共 47 条
  • [1] CHROMOGRANIN-A - POSTTRANSLATIONAL MODIFICATIONS IN SECRETORY GRANULES
    BARBOSA, JA
    GILL, BM
    TAKIYYUDDIN, MA
    OCONNOR, DT
    [J]. ENDOCRINOLOGY, 1991, 128 (01) : 174 - 190
  • [2] CLONIDINE REDUCES ELEVATED CEREBROSPINAL-FLUID CATECHOLAMINE LEVELS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    CUBEDDU, LX
    HOFFMANN, IS
    DAVILA, J
    BARBELLA, YR
    ORDAZ, P
    [J]. LIFE SCIENCES, 1984, 35 (13) : 1365 - 1371
  • [3] CEREBROSPINAL-FLUID AND PLASMA DOPAMINE-BETA-HYDROXYLASE ACTIVITY IN HUMAN HYPERTENSION
    CUBEDDU, LX
    DAVILA, J
    ZSCHAECK, D
    BARBELLA, YR
    ORDAZ, P
    DOMINGUEZ, J
    [J]. HYPERTENSION, 1981, 3 (04) : 448 - 455
  • [4] CHROMOGRANIN A CORRELATES WITH NOREPINEPHRINE RELEASE RATE
    DIMSDALE, JE
    OCONNOR, DT
    ZIEGLER, M
    MILLS, P
    [J]. LIFE SCIENCES, 1992, 51 (07) : 519 - 525
  • [5] RAISED CEREBROSPINAL-FLUID NOREPINEPHRINE IN SOME PATIENTS WITH PRIMARY HYPERTENSION
    EIDE, I
    KOLLOCH, R
    QUATTRO, VD
    MIANO, L
    DUGGER, R
    VANDERMEULEN, J
    [J]. HYPERTENSION, 1979, 1 (03) : 255 - 260
  • [6] EINSTEIN ER, 1982, PROTEINS BRAIN CSF H, P95
  • [7] SITES OF SYNTHESIS OF CHROMOGRANIN-A AND CHROMOGRANIN-B IN THE HUMAN BRAIN
    ERICKSON, JD
    LLOYD, R
    TROJANOWSKI, JQ
    IACANGELO, A
    EIDEN, E
    [J]. NEUROPEPTIDES, 1992, 21 (04) : 239 - 244
  • [8] PROTEIN SIZE AND CEREBROSPINAL-FLUID COMPOSITION
    FELGENHAUER, K
    [J]. KLINISCHE WOCHENSCHRIFT, 1974, 52 (24): : 1158 - 1164
  • [9] FISHMAN RA, 1980, CEREBROSPINAL FLUID, P186
  • [10] FRIGON RP, 1981, MOL PHARMACOL, V19, P444